Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Revue Belge De Medecine Dentaire|August 30, 2008
[Prevention of endocarditis: changes in the recommendations]Paul De Munter, Willy Peetermans, Dominique Declerck, et al.
Clinical Nuclear Medicine|July 24, 2018
Bone Scintigraphy in Poststreptococcal Periostitis With DysproteinemiaSophie Bourgeois, Willy Peetermans, Nathalie Noppe, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 15, 2007
Implementing a hospital guideline on pneumonia: a semi-quantitative reviewPieter-Jan Cortoos, Steven Simoens, Willy Peetermans, et al.
European Journal of Internal Medicine|September 12, 2006
Extremely elevated C-reactive proteinSteven Vanderschueren, Dries Deeren, Daniël C Knockaert, et al.
Therapeutic Drug Monitoring|December 3, 2024
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
Therapeutic Drug Monitoring|May 9, 2025
Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation StudyNada Dia, Sabrina De Winter, Matthias Gijsen, et al.
International Journal of Antimicrobial Agents|November 29, 2017
Higher versus standard amikacin single dose in emergency department patients with severe sepsis and septic shock: a randomised controlled trialSabrina De Winter, Joost Wauters, Wouter Meersseman, et al.
Heart, Lung & Circulation|September 6, 2018
Surgery for Active Infective Endocarditis of the Aortic Valve With Infection Extending Beyond the LeafletsAbdelmotagaly Elgalad, Amr Arafat, Tarek Elshazly, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 23, 2021
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic AnalysisSabrina De Winter, Reinier van Hest, Erwin Dreesen, et al.
Pageof 2